In 2020, Eli Lilly aims to announce deals at every quarter. It would be in the range of $1 - $5 billion. The U.S. drugmaker focuses to build up its pipeline of future products.
Its area of interest would be key therapeutic areas including immunology, pain, oncology, and neurology. However, it will focus largely on earlier stage opportunities across these areas.
In recent years, Eli Li....
Tags : Merger and Acquisitions,
comments (0)